Diabetes Increases Post-RP Metastasis Risk in Obese Men


Diabetes in obese men with prostate cancer (PCa) increases their risk of metastasis after radical prostatectomy (RP), according to researchers.

A team led by Stephen J. Freedland, MD, of the Duke Prostate Center at Duke University Medical Center in Durham, N.C., studied 2,058 U.S. veterans with PCa who were enrolled in the Shared Equal-Access Regional Cancer Hospital (SEARCH) database and underwent RP. For the cohort as a whole, diabetes at the time of RP was not associated with metastasis risk after adjusting for multiple variables, Dr. Freedland and his colleagues reported online in BJU International. When the researchers divided men into obese and non-obese groups, however, they found that diabetes in obese patients was associated with a significant fourfold increased risk of metastasis, whereas diabetes in non-obese patients was not significantly associated with metastasis risk.

Among obese men, diabetes was associated with a nonsignificant 39% increased likelihood of receiving aggressive secondary treatment (radiation or androgen deprivation therapy [ADT]). In non-obese men, diabetes was associated with a significant 37% decreased likelihood of receiving aggressive secondary treatment.

After excluding men who received adjuvant radiation or ADT, diabetes was associated with a significant 61% increased likelihood of receiving aggressive secondary treatment among obese men. Among non-obese men, diabetes was associated with a significant 41% decreased likelihood of receiving secondary treatment.

Among the diabetics, longer diabetes duration was associated with higher metastasis risk. If this finding is confirmed in future studies, the researchers stated, “the clinical implication is that men with long-standing diabetes who develop PCa may harbor a more aggressive variant, and this possibility should be kept in mind when determining treatment.”

The study found that race had no significant effect on the association between diabetes and metastasis risk.

“Our findings add to the limited research on diabetes, obesity, and PCa progression, suggesting men with diabetes and obesity together might harbor particularly aggressive disease,” the authors concluded.

The new study also supports earlier findings from Dr. Freedland's group linking diabetes to increased risk of biochemical recurrence after RP, but only in obese white men.

According to the investigators, possible biological mechanisms for the new findings include changes in the hormonal milieu of obese men with diabetes, particularly decreased plasma concentrations of total and free testosterone, as well as elevated levels of insulin and insulin-like growth factor-I. All of these conditions have been shown in previous studies to be associated with an increased PCa risk.

Read more http://www.renalandurologynews.com/diabetes-increases-post-rp-metastasis-risk-in-obese-men/article/276262/

PUA Social Network

Twitter Facebook

Contact us

The Philippine Urological Association,Inc
3rd floor. PCS Bldg., 992 EDSA, Quezon City,
Metro Manila, PHILIPPINES 1105
View Map


eMail us